Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/33472
Title: Obesity and 'functional hypogonadism' - mechanisms and management: Commentary on EJE-22-1110 "Leflutrozole in Male Obesity-Associated Hypogonadotropic Hypogonadism: Ph 2b Double-Blind RCT".
Austin Authors: Inder, Warrick J;Grossmann, Mathis 
Affiliation: Department of Diabetes and Endocrinology, Princess Alexandra Hospital, ¬†Brisbane QLD, Australia.;Faculty of Medicine, The University of Queensland, Brisbane QLD, Australia.
Medicine (University of Melbourne)
Endocrinology
Issue Date: 1-Sep-2023
Date: 2023
Publication information: European Journal of Endocrinology 2023-09-01; 189(3)
URI: https://ahro.austin.org.au/austinjspui/handle/1/33472
DOI: 10.1093/ejendo/lvad100
ORCID: 0000-0001-8261-3457
Journal: European Journal of Endocrinology
PubMed URL: 37548170
ISSN: 1479-683X
Type: Journal Article
Subjects: SERM
androgen
aromatase inhibitor
hypogonadism
testosterone
Appears in Collections:Journal articles

Show full item record

Page view(s)

34
checked on May 30, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.